A soil isolate of Actinoplanes that produces the chemically unrelated new amibiotics teichomycins A, and A2 has been proposed as a new species named Actinoplanes teichomyceticus nov. sp. (ATCC 31121). Studies of medium and fermentation conditions indicated that the highest antibiotic titers, ca 900 u/ml, are obtained in a medium containing 1 (w/v) glucose, 1 % cotton seed meal, 1 % malt extract, and 0.4% yeast extract. Both teichomycin A, and teichomycin A2 are highly active against gram-positive bacteria. Teichomycin A, shows some activity against gram-negative bacteria. Both antibiotics cured mice experimentally infected with sensitive bacteria and showed low acute toxicity. Of the two antibiotics teichomycin A2 is the more active.
In the course of our screening program for antibiotic-producing strains of Act%nomycetales of the family Actinoplanaceae, we have isolated a strain of Actinoplanes that produces two new antibacterial agents, teichomycin A, and teichomycin A2, that are highly active against grampositive pathogenic bacteria, both in vitro and in vivo. In the present paper we wish to report on the taxonomy of this strain (A 8327 of our collection), on the fermentation of the teichcmycins and on their biological properties. In a companion paper partial chemical characterizaticns of the two agents are presented''.
Materials and Methods

Organism
Strain A 8327 was isolated from a soil sample collected at Nimodi Village, Indore (India) and was deposited in the American Type Culture Collection (ATCC) as accession number 31121. The strain was kept in lyophilized form and cultured on slants of oatmeal agar.
Determination of Growth Characteristics
To examine the growth characteristics, the organism was cultivated on the various standard media suggested by SHIRLING and GOTTLIEB", with the addition of several media recommended by WAKSMAN". The inoculated media were incubated and examined after 1 and 2 weeks of growth.
Color designations were made, when necessary, by the method of MAERZ and PAUL;). The ability of the organism to utilize different carbon sources was investigated by the method described by SHIRLING and GOTTLIEB4).
The effect of temperature on growth was determined by incubating the inoculated oatmeal agar slants at temperatures ranging from 15 to 50°C.
Assay of Teichomycin A, Antibiotic activity was followed by a microbial paper-disc-agar diffusion assay, using Staphylococcus aureus ATCC 6538 as the test organism.
The bacterium was grown overnight on a slant of Penassay medium.
The microbial assay was performed on Difco Noble agar medium inoculated with 0.3 % (v/v) of an aqueous suspension of S. aureus which contained 106 cells/ml.
Petri dishes, 9 cm in diameter, were filled with 10 ml of inoculated medium and 9-mm diameter paper discs were used. The diameter of the inhibition zone was read with an optical device, after 18-hour incubation at 37°C. The potency of the fermentation broths was determined against a standard curve of teichomycin A2 containing no teichomycin A1, 1 mg of which was considered to contain 103 arbitrary antibiotic units.
The diameter of the inhibition zones was proportional to the log of the antibiotic concentration in the range of 15-250 pg/ml. The linearity of the unknown and standard curves, their parallelism and the concentration of the unknown sample were calculated by usual statistical procedures, using a computer.
Determination of Antimicrobial Spectrum and Experimental Infection
The minimal inhibitory concentration (MIC values) in liquid media and the effectiveness of the compounds in treating experimentally infected mice were assessed as previously described". T2 medium (g/liter): yeast extract 4, malt extract 10, glucose 5, Noble agar 10, distilled H20 to 1,000 ml. The solution was titrated to pH 7.3 with NaOH before sterilization. The pH after sterilization was 6.0-6.2.
Media Composition
Results
Description of the Producing Strain
Macroscopic Examination
The colonies produced on oatmeal agar medium are 5 -6 mm in diameter and have well defined and regular contours and a central dome-like protuberance with a pale orange color. A light orange to deep orange vegetative mycelium is produced on most media. However, on potato, HICKEY and TRESNER, skim milk and tyrosine agars the color of the vegetative mycelium is light brown. Soluble pigments are generally absent. In some media only a light brown soluble pigment is produced (Table 1) . A well developed powdery aerial mycelium made up of long hyphae is found on some media.
Microscopic Examination
Sporangia, abundantly produced on most media, are found mainly on the dome of the colony.
The sporangia are spherical to oval, with regular contours and have diameters ranging from 15 to 25 It.
Sporangiophores are straight, about 15 It long and 2 ,u in diameter.
The highly motile spores are spherical to oval, with diameters of 1.5 -2 ,u.
The vegetative mycelium is composed of thin, twisted and branched hyphae 0.5 -1 ,u in diameter.
Carbon Utilization
Strain A 8327 utilizes the pentoses arabinose and xylose as sole carbon sources. It grows on the hexoses glucose, fructose, mannose and mannitol but not on rhamnose or on the cyclitol, inositol.
It is able to hydrolyze the glycosidic bonds of sucrose and starch but not those of raffinose and cellulose. Lactose and salicin are poorly utilized. 
Antibiotic Susceptibility Pattern
Strain A 8327 was tested in BENNETT'S medium for antibiotic susceptibility giving the following MIC values (pg/ml): penicillin (6), ampicillin (3), chloramphenicol (6), tetracycline (1.5), novobiocin (6), neomycin (6), streptomycin (3) and rifampicin (6) . It showed low susceptibility to bacitracin (16) and erythromycin (16) and was insensitive to lincomycin (250).
Fermentation Studies
The assay procedure used to measure the antibiotic potency of fermentation samples detects both teichomycin A, and teichomycin A2, since both are coproduced by strain A 8327 and since the test organism (S. aureus) is sensitive to both antibiotics. However, when samples of pure teichomycin A, and teichomycin A2 were compared, teichomycin A, had approximately 1/3 the activity of the same weight of teichomycin A2 (Fig. 1) . Moreover, the assay measures the total activity of A, + Aa only if the inhibitory activities are additive. That such is indeed the case is shown in Fig. 1 To assess whether any major alterations in the A,/A2 ratio were introduced by the different fermentation conditions, the total antibiotic activity was also extracted and chromatographed in a system that clearly separates the two activities". Acetate does not support growth, nor does glyceraldehyde. Three-carbon sources that enter below the aldolase reaction into the E. M. pathway (glycerol, glyceric acid, pyruvate) and four carbon sources that feed into the KREBS cycle (glutamate, aspartate) supported good growth but allowed minimal antibiotic synthesis (< 20 units/ml). Starch, lactose and fructose supported growth and supported only low levels of antibiotic formation (100-150 units/ml). The disaccharide sucrose; the hexoses glucose, mannitol, mannose and galactose;
gluconate; the pentoses, xylose and arabinose; and the cyclitol, inositol, supported both biomass production and good antibiotic titers (250-500 units/ml). Ribose supported growth only sparingly with no measurable antibiotic titer. From these experiments, glucose appeared to be the best carbon source for antibiotic production giving titers ranging from 400 to 500 units/ml. The effect of different nitrogen sources added to the T2-glucose medium was studied both in flasks and in jar fermentors. The following N-sources, at 0.5% (w/v) levels, supported good growth: Pharmamedia, soy bean meal, distiller dry solubles, peanut meal, cotton seed meal, glutamate, NaNO3. Very little growth was observed when urea was used. The antibiotic titer was maximum with cotton seed meal (900 units/ml), intermediate with the other complex N-sources (300600 units/ml) and no antibiotic was detectable with glutamate, NaNOs and urea.
T2-medium, supplemented with glucose and cotton seed meal was selected from these preliminary experiments and the effects of varying their initial concentrations on the antibiotic production were studied in 4-liter jar fermentors. The best medium was found to contain 10 g/liter of both glucose and cotton seed meal ( Table 2) . The time-course of the fermentation with this medium is shown in Fig. 2 . The synthesis of antibiotic starts when the growth phase has ended and when glucose is no longer detectable in the medium. It continues more or less linearly until 80 hours, when it begins to level off. The pH of the medium decreased during the growth phase to pH 5 then rose during the antibiotic production phase.
Biological Properties
Both teichomycin A, and teichomycin A2 are very active against gram-positive pathogenic bacteria (Table 3) . Teichomycin Ai but not teichomycin A2 shows also substantial activity against several gram-negative bacteria. Neither substance shows cross-resistance to macrolides, aminoglycosides, tetracycline, penicillins, cephalosporins, rifampicin, and chloramphenicol. Teichomycin A2 but not teichomycin Ai has partial crossresistance with vancomycin.
Teichomycin Ai and teichomycin A2 have a very low ED50, when administered subcutaneously to mice challenged with a killing inoculum of sensitive bacteria ( Table 4 ). The
EDso of teichomycin Ai is of the same order of magnitude as that of erythromycin, lincomycin, vancomycin determined in parallel experiments. The EDso of teichomycin A2 is one to two orders of magnitude lower.
Teichomycin Ai injected intravenously into mice (500 mg/kg) did not cause any death.
Teichomycin A2 had a LD50 of 275 mg/kg when administered intravenously, and an LD5o greater than 1,000mg/kg when given orally or intraperitoneally.
Discussion
The colony morphology, pigmentation and the presence of motile spores bearing globose sporangia carried at the end of a sporangiophore places strain A 8327 in the genus Actinoplanes. However, the presence of a well-developed although sterile aerial mycelium, the pattern of utilization of carbon sources and the pattern of physiologic characteristics make it impossible to assign strain A 8327 to any of previously described species. For these reasons, strain A 8327 is recognized as a new species of the genus Actinoplanes, for which the specific epithet teichomyceticus is proposed. More specifically, A. teichomyceticus nov. sp. can be described and identified by the following characteristics: a) it bears large (more than 15 pm diameter), globose sporangia (like those of A. armeniacus", A. filippinensis'', A. liguriae2i, A. utahensis°'), which have regular contours (unlike A. utahensis); b) it has a well-developed aerial mycelium, like A. armeniacus, which however bears conidiospores; c) it fails to grow, under the conditions of the test, on inositol, rhamnose, raffinose and cellulose; d) it grows, although weakly, on salicin; e) it does not hydrolyze tyrosine and calcium malate; it does not coagulate litmus milk but peptonizes it.
Although the fermentation studies here reported were aimed at the practical goal of increasing the antibiotic titer and thus reducing the critical cost of supplying a quantity of pure antibiotic sufficient for the drug evaluation program, some general observations can be made.
1) The inability of the strain to grow on acetate as the only carbon source indicates either that A 8327 is not able to take up acetate or that it lacks the acetylCoA synthetase enzyme or the glyoxylate cycle or both.
2) Although glucose is the best carbon-source for antibiotic production, the antibiotic accumulates only when the glucose concentration of the medium is reduced to barely detectable levels. Whether this behavior is a direct catabolite repression or an indirect effect of change in medium pH associated with glucose consumption is open to question.
3) The ability of strain A 8327 to grow on either three-carbon or four-carbon compounds as sole carbon sources (besides yeast and malt extract ) speaks for the presence of anaplerotic pathways that accomplish gluconeogenesis. Strain A 8327 must possess PEP carboxykinase, the malate enzyme, phospho-enolpyruvate synthetase, phospho-enolpyruvate carboxylase and fructose-diphosphatase.
Preliminary chemical studies on teichomycin A2 show that the antibiotic contains D-mannose and D-glucosamine2'. It is conceivable that these carbohydrates are made from the cell pool of sugar phosphates. Furthermore, the bulk of the antibiotic molecule is made up of analogs of tyrosine and thus may stem from the same pathway which starts with the condensation of PEP and the sugar phosphate erythrose-4-phosphate.
The inability of the three-carbon and four-carbon substrates to support antibiotic synthesis, in contrast with the five-carbon and six-carbon substrates as well as oligo and polymeric carbohydrates, may reflect the existence of different levels of the pool of sugarphosphates, low with the former substrates and high with the latter ones. Alternatively, the operation of gluconeogenesis may induce a cellular situation that indirectly controls the activity (or synthesis) of the enzymes of the antibiotic synthetic pathway.
All these hypotheses must be kept in mind in defining a rational strain-improvement program through mutation and selection.
The restricted antibacterial spectrum, the absence of activity on bacteria lacking cell walls including the L form of sensitive S. aureus, the cross-resistance with vancomycin and the chemical composition" suggest that teichomycin A2 belongs to the class of glycopeptide antibiotics active as cell wall inhibitors such as vancomycin, ristomycin, ristocetin, actinoidins, LLAV290 and mannopeptins". Teichomycin A2 seems to be the most active member of this group in curing experimental infections in mice. Teichomycin A2 is the first glycopeptide antibiotic isolated from a member of the genus Actinoplanes.
Teichomycin A, also is inactive on cell wall lacking bacteria thus suggesting it acts by inhibiting cell wall synthesis. The chemical composition and the physico-chemical properties" indicate that it may belong to the class of glycolipid antibiotics such as moenomycins, diumycins, prasinomycins and macarbomycin2'. Teichomycin A, is the first example of this type antibiotic isolated from a member of the genus Actinoplanes.
